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Highlights 
 
 Improvements in outcomes for all three common foot and ankle operations.   
 The greatest outcome score improvements were with ankle fusion and 1st MTP joint 
fusion compared to hallux valgus. 
 Health economics analysis suggested all three procedures were favourable 
compared to threshold levels of cost-effectiveness.   
 The costs of ankle fusion and 1st MTPJ fusion were easily within threshold costs per 
QALY whereas hallux valgus had varying costs making it just favourable. 
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ABSTRACT 
 
This study assessed the health economics and outcomes of three common foot and ankle 
operations.   
 
Between July 2013 and October 2014 all patients undergoing ankle fusion (AF) for 
osteoarthritis, first metatarsophalangeal joint fusion for osteoarthritis (MF) or hallux valgus 
surgery (HV) were included. Patients having additional procedures were excluded. Patients 
completed the Manchester-Oxford Foot Questionnaire (MOX-FQ), the EuroQol EQ-5D-5L 
questionnaire and the EQ-VAS on presentation and at least 6 months post-operatively. 
 
63 patients undergoing AF (n=22), MF (n=22),  or HV (n=32) completed preoperative and 
postoperative questionnaires. 76 completed preoperative questionnaires and 63 completed 
the follow up questionnaires. The follow up questionnaires were completed at a median of 
12 months (range 6-24 months) following surgery. The mean age at surgery was 59 years 
(range 26-85 years). Pre-operative MOX-FQ and EQ-5D-5L scores differed significantly 
between the three groups with AF and MF patients reporting worse scores compared to HV 
patients. MOX-FQ and EQ-5D-5L significantly improved in all groups from pre-operative 
levels. MOX-FQ: AF from 53.8 (CI 56.8 – 50.8) to 22.9 (CI 30.9 – 14.9), MF from 43.0 (CI 46.4 
– 39.6) to 12.1 (CI 5.9 – 18.3), HV from 35.4 (CI 39.0 – 31.7) to 15.6 (CI 21.1 to 10.1). EQ-5D-
5L: AF from 0.30 (CI 0.43 – 0.17) to 0.66 (CI 0.55 – 0.77), MF from 0.45(CI 0.52 – 0.38) to 
0.83 (CI 0.07 – 0.07), HV from 0.71(CI 0.74 – 0.68) to 0.82 (CI 0.88 – 0.76). There was no 
significant difference in the EQ-VAS suggesting it may not be representative of foot and 
ankle health. Health economics analysis using the EQ-5D-5L data to estimate quality-
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adjusted life years (QALYs) suggested all three procedures were favourable compared to 
threshold levels of cost-effectiveness.  There were differences in estimated costs between 
the three operations with AF at £2950 (threshold cost <£5,400) and MF at £1197 (threshold 
cost <£5,780) and HV varying from £625 to £1688 (threshold cost <£1640). 
 
This study reveals that the joint-specific (MOX-FQ) and generic health (EQ-5D-5L) outcome 
scores of patients improved after AF, MF and HV. The greatest benefit from surgery was 
gained in the arthritic patient groups. In the future, the use of large population patient 
reported outcome measures data may also potentially have implications for prioritisation of 
healthcare provision, acting as an indicator of foot and ankle surgical procedures that 
produce the most benefit to patients.  
 5 
INTRODUCTION  
In recent years Patient Reported Outcome Measures (PROMs) have become an important 
tool both in clinical practice and in healthcare provision. They are seen as a key measure 
both in clinical research, and in evaluating surgical outcomes and service quality. Many of 
the specialty societies, including the British Society for Surgery of the Hand (BSSH), and the 
British Association for Spinal Surgery (BASS), have set up registries where their members can 
audit patient outcomes for the most common procedures. A central UK registry for foot and 
ankle surgery has been proposed (1), initially recording surgeons’ outcomes for AF and MF. 
This study has also included HV as it is probably the commonest patient group in foot and 
ankle surgery. 
 
Many scoring systems exist which relate specifically to the foot and ankle. One study found 
139 different outcome scales in use in the foot and ankle literature (2). A commonly used 
score in the UK is the Manchester-Oxford Foot Questionnaire (MOX-FQ) which was originally 
validated for use in hallux valgus (3), but has subsequently been validated for use in all 
regions of the foot and ankle (4). The MOX-FQ consists of 16 questions covering the three 
domains of function (standing and walking), pain, and social interaction. Pain and function 
have been shown to be strong predictors of patient satisfaction post-operatively (5,6). The 
three MOX-FQ domains are combined to form a MOX-FQ index (7), with higher scores 
indicating more severe symptoms. The EuroQol EQ-5D-5L index (8) is a standardised generic 
measure of health developed by the EuroQol group. It includes five domains of mobility, 
self-care, daily activities, pain, anxiety or depression. Each domain has 5 levels. The EQ-5D-
5L index scores range from -0.594 to 1 (full health) with negative values representing health 
states worse than death, which is assigned a score of zero (9). The EQ-5D visual analogue 
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scale (EQ-VAS) is a measure of overall health, with patients marking their health on a scale 
from 0 (worst health you can imagine) to 100 (best health you can imagine). 
 
The primary aim of this study was to compare health economy outcomes using quality-
adjusted life years (QALY) between isolated MF, isolated AF, and isolated HV. Secondary 
outcomes included comparison of three different outcome scores between the three 
procedures (MOX-FQ, EQ-5D-5L, and EQ-VAS).  
 
 
PATIENTS & METHODS  
Prospectively collected data was reviewed retrospectively, up to December 2015, on all 
patients who underwent AF, MF, or HV between 4th July 2013 and 31st October 2014. The 
operations were performed by either of the two senior authors (GS and DL), or under their 
direct supervision. Symptomatic arthritis affecting the particular joint was the primary 
indication for either AF or MF. HV correction consisted of a scarf osteotomy plus lateral soft 
tissue release (10) and an Akin osteotomy of the proximal phalanx (11) if indicated 
perioperatively. Subjects attending the out-patient clinic pre-operatively completed a paper 
questionnaire consisting of the MOX-FQ, the EQ-5D-5L, and the EQ-VAS. At a minimum of 6 
months post-operatively, the patients were initially contacted via post and asked to 
complete the same questionnaires. The few patients who did not reply by post where then 
contacted by telephone. Patients undergoing concurrent ipsilateral forefoot surgery such as 
Weil’s osteotomy or a proximal interphalangeal joint fusion were excluded. Those 
undergoing revision surgery or simultaneous bilateral surgery were also excluded, as were 
those who had rheumatoid arthritis. 
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For health economic evaluation the quality-adjusted life year (QALY) is routinely used. The 
QALY seeks to combine effects in terms of both quality of life and length of life, enabling the 
benefits of different interventions to be compared on the same scale(12). The National 
Institute for Health and Care Excellence (NICE) (13) recommends that EuroQol EQ-5D (14) is 
used to estimate QALYs. The QALY can be calculated using the area-under-curve method 
(15) with linear interpolation (this assumes a straight-line change between points, rather 
than an immediate improvement). In line with previous work (16), we estimated the QALY 
gain between the individual pre- and post-operation EQ-5D-5L scores, based on the 
assumption of a 6 month follow up period and that without the procedure in question the 
pre-operative score would have been maintained (see Appendix 1). Threshold analysis (12) 
was then conducted on the mean QALY gain for each procedure in order to estimate the 
maximum cost at which the procedure is likely to be cost-effective based on the threshold 
value of £20000 per QALY (13). Indicative costs were subsequently identified for each 
procedure and compared to these maximum costs in order to assess whether the 
procedures were likely to have favourable levels of cost-effectiveness. 
 
A one-way ANOVA was used for between groups statistical analysis, and a paired student’s 
t-test for the pre- and post-operative score analysis. A p-value of <0.05 was accepted as 
being statistically significant. Local audit committee approval was obtained for the study. 
 
RESULTS  
In total 143 patients referred to the Norfolk and Norwich University Hospital received one of 
the three procedures in the study time period. After application of the exclusion criteria 85 
 8 
patients were identified (figure 1). 76 patients had completed pre-operative questionnaires, 
and 63 of these went on to complete MOXFQ and EQ-5D post-operative questionnaires at a 
median of 12 months following surgery (range 6-24 months). However all data from the 76 
patients completing pre-operative questionnaires was used in statistical analysis. The 
average age was 59 years (range 26-85 years) and 53 (70%) patients were female (table 1). 
The HV group was mainly female and had a wider age range compared to the AF and MF 
groups. 
 
MOX-FQ 
Mean pre-operative MOX-FQ scores were AF 53.8 (CI 56.8 – 50.8), MF from 43.0 (CI 46.4 – 
39.6), HV from 35.4 (CI 39.0 – 31.7) (figure 2). These differed significantly between the three 
groups (p<0.0001) with AF patients reporting the worst scores, and HV patients the best 
scores. There was significant improvement in the MOX-FQ in all groups (p<0.0001). The 
mean post-operative scores were AF 22.9 (CI 30.9 – 14.9), MF 12.1 (CI 5.9 – 18.3), HV 15.6 
(CI 21.1 to 10.1). However, there was no significant difference between the post-operative 
scores in each group (p=0.1041), AF 0.66 (CI 0.55 – 0.77), MF 0.83 (CI 0.07 – 0.07), HV 0.82 
(CI 0.88 – 0.76).  
 
EQ-5D-5L 
Mean pre-operative EQ-5D-5L were AF 0.30 (CI 0.43 – 0.17), MF 0.45(CI 0.52 – 0.38), HV 
0.71 (CI 0.74 – 0.68) (figure 3). These scores differed significantly between the groups 
(p<0.0001), again with ankle fusion patients reporting the worst scores, and hallux valgus 
patients the best scores. Mean post-operative scores were AF 0.66 (CI 0.55 – 0.77), MF 0.83 
(CI 0.07 – 0.07), HV 0.82 (CI 0.88 – 0.76). EQ-5D-5L showed a statistically significant 
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improvement following surgery in all three conditions (MTPJ p<0.0001; ankle p=0.00013; 
hallux valgus p=0.0027). Post-operative EQ-5D-5L did not differ between groups (p=0.0678).  
 
EQ-VAS 
The EQ-VAS showed a significant difference between the surgical groups pre-operatively 
(p=0.0448), with AF 73.5(CI 80.9 – 66.1), MF 72.2 (CI 81.5 – 62.9), HV 83.5(CI 88.4 – 78.6). 
There was no significant difference between the groups post-operatively with AF 72.8(CI 
83.1 – 62.5), MF 78.4(CI 85.0 – 71.8), HV 81.8(CI 86.4 – 77.2), and there was no significant 
improvement between pre- and post-op scores for each type of surgery (Table 2). 
 
Clinical Outcomes 
None of the patients in the study population underwent revision surgery or had removal of 
metalwork during the study period. A total of 4 out of the 22 AF patients had post operative 
computer tomography (CT) scans for ongoing pain. Two had non unions and two had solid 
fusions. One AF patient sustained a stress fracture at the proximal screw four months post-
operatively. This was managed conservatively and healed by 7 months post-operation. 
There were no MF non-unions, although one patient with a poor MOX-FQ score had a CT 
scan demonstrating union.  
 
 
 
Health Economics 
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Threshold analysis was used to determine the cost below that an intervention would look to 
have a favourable cost per QALY, given the estimated QALY gain [12] (Table 3). NICE  
recommends a cost of £20,000 per QALY. 
 
For the cost of the intervention in England the NHS National Schedule of Reference Costs 
2013-14 was used (Table 4). For this the ICD-10, OPCS-4, HRG4 codes were required. The 
International Statistical Classification of Diseases and Related Health Problems 10th revision 
(ICD-10) is a World Health Organisation medical classification for diseases. The Office of 
Population, Censuses and Surveys Classification of Surgical Operations and Procedures 4th 
revision (OPCS-4) is a NHS England classification translating surgical procedures into codes. 
The Healthcare Resource Group 4 (HRG4) is a NHS England classification of patient activity, 
based on procedures and diagnosis, to determine reimbursement for providers. 
 
For AF there is a cost of £2950 and in this study’s patient group a QALY gain of 0.270 
(compared to what would have happened without the intervention). As the incremental 
cost of the intervention is <£5,400 then the cost per QALY is likely to be favourable. 
  
For MF there is a cost of £1197 and in this study’s patient group a QALY gain of 0.289 
(compared to what would have happened without the intervention). As the incremental 
cost of the intervention is <£5,780 then the cost per QALY is likely to be favourable. 
 
For HV the costing is not as clear due to the variations in surgery and coding requirements. 
OPCS-4 and HRG4 codes stipulate if a soft tissue procedure is performed with hallux valgus 
surgery then this code has to be listed first. This leads to a considerable reduction in the 
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costing. For hallux valgus surgery there is a cost ranging from £625 to £1688 and in this 
study’s patient group a QALY gain of 0.082 (compared to what would have happened 
without the intervention). As the incremental cost of the intervention, £1640, is similar to 
the top end cost then the cost per QALY is just likely to be favourable. 
 
 
DISCUSSION 
The results of this study show that both foot and ankle specific (MOX-FQ), and generic (EQ-
5D-5L) scores differ between patients who have different pathologies of the foot and ankle. 
Arthritic conditions affecting the ankle joint (AF group) lead to the worst MOX-FQ and EQ-
5D-5L scores followed by arthritis of the first MTP joint (MF group), with hallux valgus 
patients (HV group) recording the best scores of the three study groups. Both MOX-FQ and 
EQ-5D-5L show a statistically significant improvement following surgery in the three groups. 
These results are broadly in line with previous studies which have suggested that the 
MOXFQ is the best disease-specific score for hallux valgus patients (17), and that it is more 
responsive in foot and ankle patients than EQ-5D-5L and other generic scoring systems (18). 
 
The minimum change for a MOX-FQ score to be considered significant is 7 points (19). In 
this study, the mean change in each of the three groups was greater than 7. However, there 
were ten patients who did not achieve this level: 3 AF, 2 MF and 5 HV. The EQ-VAS showed a 
difference in pre operative scores, but there was no significant change from pre-op to post-
op in any of the three groups (the post operative scores did not differ significantly between 
the groups). This suggests the EQ-VAS may not be responsive to foot and ankle health. 
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Patients may perceive their overall health as representing something different than a 
specific problem related to foot and ankle pain and mobility. 
 
From the health economics analysis using the EQ-5D-5L the three interventions can be 
judged to be cost-effective procedures. Hallux valgus surgery emerges as having a cost that 
is similar to the threshold cost. However coding requirements demand if a soft tissue 
procedure is involved then this has to be coded first. This leads to the cost of the procedure 
to be much less than the threshold cost. Most surgeons would agree that a first metatarsal 
osteotomy for hallux valgus always requires release of the tight lateral tissue and reefing of 
the medial soft tissues. Therefore all hallux valgus surgery will be coded at a lower cost. 
There are a number of potential criticisms of this analysis. It is assumed the quality of life 
would not have changed without intervention. For the three interventions listed surgery is 
only advised when patients are unable to manage their symptoms with painkillers, altered 
footwear or altered activities. All three conditions have a slow onset and it is likely patients 
have lived with their symptoms for sometime prior to presentation. The three conditions 
affect mobility and unless the patients stop walking (highly unlikely) they are likely to have 
continued symptoms without an intervention. For these interventions only the cost 
associated with the initial procedure have been considered. Other costs e.g. physiotherapy 
and medication costs, might differ between groups and the analysis makes the assumption 
that all other costs are the same in both groups. Though this might be a simplification it is 
recognised that cost-effectiveness studies should concentrate on those resources that are 
expected to differ between groups, and that healthcare resource groupings are often used 
to estimate unit costs [20]. 
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The limitations for this study are the relatively small number of patients with a variable 
follow up.  There is a risk of bias from the patients lost to follow up. In total 63 out of the 76 
(83%) patients meeting the inclusion criteria with pre-operative data were contactable for 
post-operative scores. Excluding those patients who had rheumatoid arthritis, multiple 
surgical procedures, revision procedures and bilateral procedures strengthens the study 
enabling the particular disease process to be studied in isolation. 
 
Patient reported outcome measures are undoubtedly of use for clinical audit, quality 
improvement, and identification of surgeon outliers (21, 22). However, the quality of their 
measurement properties (23), and hence their use in rationalising surgical services and 
predicting patients’ post-operative outcomes have been shown to be limited for other 
orthopaedic conditions (24); this is also likely to be the case for foot and ankle conditions. 
Further research needs to be undertaken to ascertain the best outcome measure for foot 
and ankle patients’ general health, and disease-specific health. Introduction of the proposed 
national database of foot and ankle outcomes will allow analysis of much larger patient 
numbers and more valid conclusions may then be drawn regarding the relevant benefits of 
various foot and ankle procedures. 
 
CONCLUSIONS 
The results in this study show that patients with arthritic conditions of the ankle (AF group) 
and great toe (MF group) score significantly worse pre-operatively than those with hallux 
valgus (HV group). Surgical management of the three conditions studied improved the 
patients’ joint-specific (MOX-FQ) and generic health (EQ-5D-5L) outcome measures in all 
groups. The greatest benefit from surgery was gained in the AF and MF groups. In the 
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future, the use of large population patient reported outcome measures data will aid foot 
and ankle surgeons when counseling patients regarding likely post-operative outcomes, and 
serve to inform patients’ expectations of surgery. They may also potentially have 
implications for prioritisation of healthcare provision, acting as an indicator of foot and 
ankle surgical procedures that produce the most benefit to patients.  
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Figure 1. 
Flowchart showing patient inclusion and exclusion criteria 
 
 
  
Assessed for eligibility (n=143) 
 
AF, MF or HV surgery between 04.07.2013 and 31.10.2014 
Patients under two senior authors care at Norfolk & Norwich University Hospitals 
 
Pre and post-op questionnaires completed 
(n=63) 
No post-op scores (n=13) 
Inclusion criteria (n=76) 
 
with pre operative MOX-FQ 
and EQ-5D-5L scores 
Exclusion criteria  (n=58) 
 
Bilateral, multiple procedures, 
rheumatoid or revision surgery 
  
No pre op scores (n=9)  
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Figure 2.  
Mean pre- and post-operative MOX-FQ scores showing 95% confidence intervals for each 
group. 
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Figure 3.  
Mean pre- and post-operative EQ-5D scores showing 95% confidence intervals for each 
group. 
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Table 1.  
Demographics of patients included in the three surgical groups 
 
 1st MTPJ fusion Ankle Fusion Hallux Valgus 
Surgery 
Patients (Total 76) 
(Complete datasets 63) 
22 
(17) 
22 
(19) 
32 
(27) 
Male:Female  
 
10:12 11:11 2:30 
Mean Age at time of surgery 
(yrs) (range) 
62 (43-85) 68 (41-81) 56 (26-78) 
Median time post-op 
(months) (range) 
12 (6-24) 15 (7-24) 8 (6-21) 
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Table 2. 
Mean EQ-5D VAS pre and post operative scores for the three surgical groups. 
 
 1st MTPJ fusion Ankle fusion Hallux Valgus 
correction 
p-value (one 
way ANOVA) 
Pre-op EQ-5D VAS 
mean (SD) 
72.16  
(22.20) 
73.50 
(17.71) 
83.52 
(14.09) 
0.0448 
Post-op EQ-5D VAS 
mean (SD) 
78.42 
(15.83) 
72.76 
(24.62) 
81.80 
(14.38) 
0.2194 
p-value (paired t-test) 0.06 0.8178 0.7668  
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Table 3. 
Threshold analysis 
 
  
QALYs for 
standard care  
 QALYs for 
intervention 
Incremental 
QALY gain 
Threshold 
cost 
1st MTPJ fusion 0.447 0.736 0.289 £5,780 
Ankle fusion 0.304 0.574 0.270 £5,400 
Hallux valgus 0.713 0.795 0.082 £1,640 
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Table 4.  
Codes with descriptions 
 
Operation ICD-10 OPCS-4 HRG4 
1st MTPJ fusion 
 
HB34E 
Minor foot procedure 
non trauma 19 years & 
over Category 2 
 £1197 
 
W593 
Fusion of first 
metatarsalphalangeal 
joint NEC 
 
M202 
Hallux rigidus 
 
Ankle fusion HB32A 
Intermediate foot 
procedure non trauma 19 
years & over Category 2 
£2950 
 
W621 
Primary arthrodesis 
and internal fixation 
of joint 
 
M1997 
Arthrosis unspecified: 
Ankle and foot joint 
 
Hallux valgus 
 
HB33E 
Intermediate foot 
procedure non trauma 19 
years & over Category 1 
£1688 
 
W153 
Osteotomy of first 
metatarsal bone NEC 
 
M201 
Hallux Valgus 
(acquired) 
 
Hallux valgus HB35C - Minor Foot 
Procedures for Non-
Trauma category 1 
without CC 
 
£625 
 
W791 
Soft tissue correction 
of hallux valgus 
 
W153 
Osteotomy of first 
metatarsal bone NEC 
M201 
Hallux Valgus 
(acquired) 
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Appendix 1. 
QALY calculations with EQ-5D-5L 
 
1st 6 month 
standard (i.e. do nothing) = (((mean eq5d score before surgery + mean eq5d score before 
surgery) / 2) x (6/12) 
intervention (i.e. operate) = (((mean eq5d score before surgery + mean eq5d score after 
surgery at 6 months) / 2) x (6/12) 
 
2nd 6 months 
standard (i.e. do nothing) = (((mean eq5d score before surgery + mean eq5d score before 
surgery) / 2) x (6/12) 
intervention (i.e. operate) = (((mean eq5d score after surgery at 6 months + mean eq5d 
score after surgery at 6 months) / 2) x (6/12) 
 
Threshold cost 
£20,000 x Incremental QALY gain 
 
